Correlation Between Day One and Exelixis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Exelixis, you can compare the effects of market volatilities on Day One and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Exelixis.

Diversification Opportunities for Day One and Exelixis

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Day and Exelixis is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Day One i.e., Day One and Exelixis go up and down completely randomly.

Pair Corralation between Day One and Exelixis

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Exelixis. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.07 times less risky than Exelixis. The stock trades about -0.1 of its potential returns per unit of risk. The Exelixis is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest  2,832  in Exelixis on August 24, 2024 and sell it today you would earn a total of  651.00  from holding Exelixis or generate 22.99% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Exelixis

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Exelixis 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Day One and Exelixis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Exelixis

The main advantage of trading using opposite Day One and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.
The idea behind Day One Biopharmaceuticals and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes